NASDAQ: RVMD - Revolution Medicines, Inc.

Yield per half year: +46.86%
Sector: Healthcare

Share chart Revolution Medicines, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Revolution Medicines, Inc., компания, занимающаяся прецизионной онкологией, специализируется на разработке методов лечения, направленных на подавление мишеней, в первую очередь, в сигнальных путях RAS и mTOR. Основным кандидатом на продукт компании является RMC-4630, ингибитор SHP2, который находится в фазе 1b> F2 исследования для лечения РАС-зависимых опухолей. Его продукты на доклинической стадии включают мутантные белки RAS; SOS1, белок, который превращает RAS (OFF) в RAS (ON) в клетках; и RMC-5552, ингибитор mTORC1. Revolution Medicines, Inc.

More details
заключила соглашение о сотрудничестве с Санофи в области исследования и разработки ингибиторов SHP2. Компания была основана в 2014 году, ее штаб-квартира находится в Редвуд-Сити, штат Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

P/S 62.6
P/BV 5.67
EV/EBITDA 0.3393
EBITDA -0.0486
Цена ао 53.5
Сайт https://www.revmed.com
Число акций ао 0.11315 млрд
Выручка 0.05
Див.доход ао 0
ISIN US76155X1000
Валюта usd
IPO date 2020-02-13
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: +2.27% (52.31)
Change price per week: +8.08% (49.5)
Change price per month: +22.23% (43.77)
Change price per 3 month: +15.95% (46.14)
Change price per half year: +46.86% (36.43)
Change price per year: +81.85% (29.42)
Change price per 3 year: +69.57% (31.55)
Change price per year to date: +149.53% (21.44)
All parameters

Underestimation

Title Value Grade
P/S 282.39 1
P/BV 1.79 8
P/E 0 0
EV/EBITDA -5.57 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -20.89 0
ROE, % -23.89 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.184 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % -76.84 0
Yield Ebitda, % 883.28 10
Yield EPS, % 328.03 10
Total: 8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
14.10.2024 16.10.2024 Kelsey Stephen Michael
See Remarks		 Sale 49.49 824 800 16666 0 -0.02 link
14.10.2024 16.10.2024 Kelsey Stephen Michael
See Remarks		 Purchase 4.09 68 164 16666 0 0.02 link
16.09.2024 18.09.2024 Horn Margaret A
Chief Operating Officer		 Sale 44.19 191 387 4331 0 -0.01 link
16.09.2024 18.09.2024 GOLDSMITH MARK A
See Remarks		 Sale 44.19 517 686 11715 0 -0.02 link
16.09.2024 18.09.2024 Anders Jack
Chief Financial Officer		 Sale 44.19 99 162 2244 0 0 link
16.09.2024 16.09.2024 Anders Jack
Officer		 Purchase 42.12 77 164 1832 0 0 link
15.07.2024 17.07.2024 Kelsey Stephen Michael
See Remarks		 Sale 46.47 774 515 16667 0 -0.02 link
15.07.2024 17.07.2024 Kelsey Stephen Michael
See Remarks		 Purchase 4.09 68 168 16667 0 0.02 link
03.05.2024 03.05.2024 Anders Jack
Chief Financial Officer		 Sale 40.03 400 300 10000 0 -0.01 link
03.05.2024 03.05.2024 Anders Jack
Chief Financial Officer		 Purchase 2.68 26 800 10000 0 0.01 link
10.04.2024 12.04.2024 Patel Sushil
Director		 Sale 37 79 735 2155 0 0 link
10.04.2024 12.04.2024 Patel Sushil
Director		 Purchase 16.8 36 204 2155 0 0 link
27.03.2024 28.03.2024 Cislini Jeff
General Counsel		 Sale 30.99 46 485 1500 0 0 link
18.09.2023 20.09.2023 Anders Jack
Chief Financial Officer		 Sale 31.31 44 679 1427 0 0 link
18.09.2023 20.09.2023 Cislini Jeff
General Counsel		 Sale 31.31 38 010 1214 0 0 link
18.09.2023 20.09.2023 GOLDSMITH MARK A
See Remarks		 Sale 31.31 252 171 8054 0 -0.01 link
18.09.2023 20.09.2023 Kelsey Stephen Michael
See Remarks		 Sale 31.31 64 499 2060 0 0 link
10.03.2023 10.03.2023 Schroeder Thilo
Director		 Purchase 20.46 2 046 000 100000 0 0.14 link
26.10.2022 28.10.2022 Horn Margaret A
See Remarks		 Sale 20.15 358 025 17768 0 -0.02 link
22.07.2022 26.07.2022 Schroeder Thilo
Director		 Purchase 20 5 000 000 250000 0 0.34 link
08.06.2022 10.06.2022 Third Rock Ventures III, L.P.
10% Owner		 Sale 20.25 8 503 000 419901 0 -0.57 link
28.03.2022 29.03.2022 Schroeder Thilo
Director		 Purchase 24.71 17 915 725 0 0 link
25.03.2022 29.03.2022 Schroeder Thilo
Director		 Purchase 24.79 1 041 180 42000 0 0.06 link
17.09.2021 21.09.2021 Horn Margaret A
See Remarks		 Sale 30.02 14 380 479 0 0 link
17.09.2021 21.09.2021 GOLDSMITH MARK A
See Remarks		 Sale 30.02 45 961 1531 0 0 link
17.09.2021 21.09.2021 Wang Xiaolin
See Remarks		 Sale 30.02 7 505 250 0 0 link

Institutions Volume Share, %
Wellington Management Group, LLP 14882086 9.04
Vanguard Group Inc 14634391 8.89
Blackrock Inc. 12954314 7.87
Farallon Capital Management Llc 6736854 4.09
Nextech Invest Ag 6296740 3.82
State Street Corporation 6253361 3.8
BVF Inc. 5981212 3.63
Casdin Capital, LLC 5714775 3.47
Alphabet Inc. 5301512 3.22
Baker Brothers Advisors, LLC 5148657 3.13

ETF Share, % Profitability for 1 year, % Dividends, %
Tema Oncology ETF 3.12948 30.22646114903 0.55
Principal Healthcare Innovators ETF 0.73744 618.4964157054 0.8416
Range Cancer Therapeutics ETF 1.88416 47.24446537918 0.11955
Avantis U.S. Equity ETF 0.01011 30.365392144069 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.90584 63.040315712071 0.33
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.17017 30.938355271732 1.42082
ProShares Ultra Nasdaq Biotechnology 0.48305 51.697637072723 0.85651
BNY Mellon US Mid Cap Core Equity ETF 0.19106 30.412321007464 1.5641
Convergence Long/Short Equity ETF -0.33179 38.084112149533 1.56428
Dimensional U.S. Core Equity 2 ETF 0.01916 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.01188 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00411 31.530984204131 1.3557
Vanguard ESG U.S. Stock ETF 0.01 32.395678092399 1.26927
iShares ESG Aware MSCI USA Small-Cap ETF 0.08147 31.110458284371 1.49366
First Trust Multi Cap Growth AlphaDEX Fund 0.14682 41.560262822399 1.02425
Fidelity MSCI Health Care Index ETF 0.07732 16.20294599018 1.46057
First Trust Mid Cap Core AlphaDEX Fund 0.16314 32.157409393095 1.65423
First Trust Mid Cap Growth AlphaDEX Fund 0.48748 39.290639813144 0.9035
First Trust US Equity Opportunities ETF 0.29807 -95.311633281972 0.69524
First Trust Nasdaq BuyWrite Income ETF 0.18395 7.2708653353815 0.92977
Goldman Sachs Innovate Equity ETF 0.14041 29.658020073179 1.20987
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.09767 31.359936575053 1.41955
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.0135 32.996534978682 1.42661
ProShares Hedge Replication ETF 0.04096 5.9237999659878 1.47892
Humankind US Stock ETF 0.03035 18.809430395549 1.99919
Invesco Nasdaq Biotechnology ETF 0.73389 28.578975171685 0.8565
iShares Morningstar Small-Cap ETF 0.13634 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.09999 33.628071953382 0.72598
iShares Morningstar Small Cap Value ETF 0.17568 26.701717953559 2.50476
iShares Russell 2000 Growth ETF 0.33385 38.042556988 0.6026
iShares Russell 3000 ETF 0.0121 31.230028873917 1.43482
John Hancock Multifactor Mid Cap ETF 0.03841 29.665565648225 1.52586
John Hancock Multifactor Small Cap ETF 0.6588 29.343594166631 1.54912
iShares Morningstar Small-Cap ETF 0.13634 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.09999 682.83677107207 0.72598
iShares Morningstar Small-Cap Value ETF 0.17568 226.82308420057 2.50476
Direxion Daily S&P Biotech Bull 3x Shares 0.68928 4067.9190751445 0.25924
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.04321 32.025164769323 1.75869
Schwab U.S. Small-Cap ETF 0.15533 -34.641922436355 1.51433
Schwab U.S. Broad Market ETF 0.01071 -56.193181818182 1.43354
SoFi Next 500 ETF 0.07351 29.558208955224 1.43041
SPDR Portfolio MSCI Global Stock Market ETF 0.00267 23.658352229781 2.19607
iShares U.S. Tech Breakthrough Multisector ETF 0.1156 36.3745 0.73986
FlexShares Morningstar US Market Factor Tilt Index Fund 0.02173 31.776653355295 1.69572
ProShares UltraPro Russell2000 0.14951 89.821266282945 1.47873
Vanguard U.S. Momentum Factor ETF 0.14 45.845704753962 1.05834
Vanguard Russell 3000 ETF 0.01 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.31 37.361289927043 0.60264
Vanguard Russell 2000 ETF 0.24 32.773459189339 1.48801
Vanguard Russell 2000 Value ETF 0.17 28.896858768241 2.37825
Vanguard Extended Market ETF 0.08 33.889077917659 1.34786
Future Tech ETF 0.73744 426.33969118983 0.8416



Head Job title Payment Year of birth
Mr. Jack Anders Chief Financial Officer 544.8k 1977 (47 years)
Mr. Walter Reiher Ph.D. Chief Information Officer N/A
Dr. Kevan M. Shokat Ph.D. Academic Co-Founder & Member of Scientific Advisory Board N/A
Dr. Mark A. Goldsmith Ph.D. CEO, President & Chairman 1.05M 1962 (62 years)
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. President of Research & Development 779k 1961 (63 years)
Ms. Margaret A. Horn J.D. Chief Operating Officer 775.6k 1963 (61 year)
Ms. Xiaolin Wang Executive Vice President of Development 604.1k 1971 (53 years)
Dr. Martin D. Burke M.D., Ph.D. Co-Founder & Chairman of Scientific Advisory Board N/A
Dr. Michael A. Fischbach Ph.D. Academic Co-Founder & Member of Scientific Advisory Board N/A 1981 (43 years)
Ms. Jan Smith Ph.D. Chief Scientific Officer N/A

Address: United States, Redwood City, CA , 700 Saginaw Drive - open in Google maps, open in Yandex maps
Website: https://www.revmed.com